NCT00610870View on ClinicalTrials.gov

Effect of Atorvastatin Administration Before Primary Percutaneous Coronary Intervention

NACompletedINTERVENTIONAL
Enrollment

173

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

August 31, 2009

Conditions
Angioplasty, Transluminal, Percutaneous Coronary
Interventions
DRUG

atorvastatin

atorvastatin 80mg/day before primary coronary intervention

Trial Locations (1)

135-710

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT00610870 - Effect of Atorvastatin Administration Before Primary Percutaneous Coronary Intervention | Biotech Hunter | Biotech Hunter